World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2023

D-Index & Metrics

Medicine

D-Index
147
Citations
81436
World Ranking
1282
National Ranking
133

Research.com Recognitions

  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Derek M. Yellon is affiliated with University College London in the United Kingdom. Their research primarily spans the field of Medicine, with particular focus on cardiology and molecular biology. The scientist's work covers several subfields including Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology, Endocrinology, Diabetes and Metabolism, and Emergency Medicine.

The main research topics addressed by Derek M. Yellon include:

  • Cardiac Ischemia and Reperfusion
  • Cardiac Arrest and Resuscitation
  • Anesthesia and Neurotoxicity Research
  • Diabetes Treatment and Management
  • Cardiac electrophysiology and arrhythmias
  • Intensive Care Unit Cognitive Disorders
  • Acute Myocardial Infarction Research

The scientist has contributed significantly to various publication venues, predominantly in cardiovascular and cardiology research. Frequent publication venues are:

  • Basic Research in Cardiology
  • Cardiovascular Drugs and Therapy
  • European Heart Journal
  • Cardiovascular Research
  • Journal of Cellular and Molecular Medicine

Derek M. Yellon has collaborated with multiple researchers, frequently co-authoring publications. Notable frequent co-authors include:

  • Sean M. Davidson
  • Derek J. Hausenloy
  • Marina Basalay
  • Siavash Beikoghli Kalkhoran
  • Pelin Golforoush

Their recent notable papers include:

  • "A small-molecule PI3Kα activator for cardioprotection and neuroregeneration" (2023) published in Nature
  • "IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action" (2021) published in Basic Research in Cardiology
  • "Mouse models of atherosclerosis and their suitability for the study of myocardial infarction" (2020) published in Basic Research in Cardiology
  • "Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection" (2023) published in Redox Biology
  • "The cytokine storm of COVID-19: a spotlight on prevention and protection" (2020) published in Expert Opinion on Therapeutic Targets

Best Publications

  • Myocardial Reperfusion Injury

    Derek M Yellon;Derek J Hausenloy

  • Myocardial ischemia-reperfusion injury: a neglected therapeutic target

    Derek J. Hausenloy;Derek M. Yellon

  • Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

    Derek M. Yellon;James M. Downey

  • Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.

    M S Marber;D S Latchman;J M Walker;D M Yellon

  • The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion

    M J Walker;M J Curtis;D J Hearse;R W Campbell

  • New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

    Derek J Hausenloy;Derek M Yellon

  • Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt Pathway

    Andrew Tsang;Derek J. Hausenloy;Mihaela M. Mocanu;Derek M. Yellon

  • Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.

    M. S. Marber;R. Mestril;Shun-Hua Chi;M. R. Sayen

  • Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury

    Sang Bing Ong;Sapna Subrayan;Shiang Y. Lim;Derek M. Yellon

  • Preconditioning the human myocardium.

    D.M Yellon;A.M Alkhulaifi;W.B Pugsley

  • Anthracycline Chemotherapy and Cardiotoxicity

    John V McGowan;Robin Chung;Angshuman Maulik;Izabela Piotrowska

  • Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial

    Derek J Hausenloy;Peter K Mwamure;Vinod Venugopal;Joanne Harris

  • Cardiovascular remodelling in coronary artery disease and heart failure

    Gerd Heusch;Peter Libby;Bernard Gersh;Derek Yellon

  • Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury

    Amal K. Bose;Mihaela M. Mocanu;Richard D. Carr;Christian L. Brand

  • Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

    Derek J Hausenloy;Helen L Maddock;Gary F Baxter;Derek M Yellon

  • Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.

    Derek J. Hausenloy;Luciano Candilio;Richard Evans;Cono Ariti

  • De novo cardiomyocytes from within the activated adult heart after injury

    Nicola Smart;Sveva Bollini;Karina N. Dubé;Joaquim M. Vieira

  • Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

    Michel Ovize;Gary F. Baxter;Fabio Di Lisa;Péter Ferdinandy

  • Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

    Derek J. Hausenloy;Derek M. Yellon

  • Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling

    Anne K. Jonassen;Michael N. Sack;Ole D. Mjøs;Derek M. Yellon

Frequent Co-Authors

Derek J. Hausenloy
Derek J. Hausenloy National University of Singapore
Sean M. Davidson
Sean M. Davidson University College London
David J. Hearse
David J. Hearse St Thomas' Hospital
James M. Downey
James M. Downey University of South Alabama
Gerd Heusch
Gerd Heusch University of Duisburg-Essen
Hans Erik Bøtker
Hans Erik Bøtker Aarhus University Hospital
David S. Latchman
David S. Latchman University College London
Michael N. Sack
Michael N. Sack National Institutes of Health
Michel Ovize
Michel Ovize Inserm : Institut national de la santé et de la recherche médicale
Rainer Schulz
Rainer Schulz University of Giessen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a traditional path. Many students are turning to flexible and affordable online programs to build rewarding healthcare careers. For example, if you are interested in leadership within the healthcare sector, earning a health administration degree online can provide the skills needed for supervisory roles in hospitals and clinics.

Those seeking advanced credentials might also consider the cheapest mha online programs to gain a solid foundation in healthcare management without overspending. Nurses looking to expand their clinical and leadership roles should explore the best dnp programs online to achieve the highest level of nursing practice.

Pharmacists can advance their expertise by enrolling in a 3 year online pharmd program, which allows working professionals to earn a doctorate more efficiently. These diverse online options help you balance career growth, flexibility, and affordability while pursuing your goals in healthcare.

Best Scientists Citing Derek M. Yellon

Trending Scientists